Kenosha, WI, United States of America

John K Lynch


 

Average Co-Inventor Count = 13.2

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2000-2005

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **John K. Lynch: Innovator in Pharmaceutical Compounds**

Introduction

John K. Lynch is a notable inventor based in Kenosha, Wisconsin, recognized for his contributions to the field of pharmaceuticals with five patents to his name. His work focuses on developing innovative compounds that address various health-related issues, particularly those related to metabolic and inflammatory disorders.

Latest Patents

Lynch's latest patents include "Antagonists of Melanin Concentrating Hormone Receptor." This invention presents compounds that act as antagonists of the melanin concentrating hormone receptor-1 (MCH-R1). The compounds are characterized by specific formulas, involving coumarin and quinolone variants. These innovations aim to treat MCH-R1-related disorders, especially obesity and overweight conditions.

Another significant patent is related to "Cell Adhesion-Inhibiting Anti-inflammatory and Immune-suppressive Compounds." This invention introduces novel cinnamide compounds that can be utilized in treating inflammatory and immune diseases. It also encompasses pharmaceutical compositions containing these compounds and various methods for inhibiting inflammation or suppressing immune responses in mammals.

Career Highlights

John K. Lynch currently works at Abbott Laboratories Corporation, a company renowned for its commitment to health care innovation. In his role, Lynch has effectively contributed to advancements in pharmaceutical sciences through his inventive efforts.

Collaborations

Throughout his career, Lynch has collaborated with other respected professionals in the field, including Mark W. Holladay and Hao Bai. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge solutions to complex health challenges.

Conclusion

In summary, John K. Lynch exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborative efforts are paving the way for effective treatments of obesity and inflammatory conditions. Through his work at Abbott Laboratories Corporation, Lynch continues to make a significant impact on health and wellness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…